313 related articles for article (PubMed ID: 32752018)
1. Proteomic Research in Peritoneal Dialysis.
Bonomini M; Borras FE; Troya-Saborido M; Carreras-Planella L; Di Liberato L; Arduini A
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32752018
[TBL] [Abstract][Full Text] [Related]
2. A prospective, proteomics study identified potential biomarkers of encapsulating peritoneal sclerosis in peritoneal effluent.
Zavvos V; Buxton AT; Evans C; Lambie M; Davies SJ; Topley N; Wilkie M; Summers A; Brenchley P; Goumenos DS; Johnson TS
Kidney Int; 2017 Oct; 92(4):988-1002. PubMed ID: 28673451
[TBL] [Abstract][Full Text] [Related]
3. Biomarker research to improve clinical outcomes of peritoneal dialysis: consensus of the European Training and Research in Peritoneal Dialysis (EuTRiPD) network.
Aufricht C; Beelen R; Eberl M; Fischbach M; Fraser D; Jörres A; Kratochwill K; LópezCabrera M; Rutherford P; Schmitt CP; Topley N; Witowski J
Kidney Int; 2017 Oct; 92(4):824-835. PubMed ID: 28797473
[TBL] [Abstract][Full Text] [Related]
4. Surgical Complications of Peritoneal Dialysis.
Mihalache O; Doran H; Mustăţea P; Bobircă F; Georgescu D; Bîrligea A; Agache A; Pătraşcu T
Chirurgia (Bucur); 2018; 113(5):611-624. PubMed ID: 30383988
[TBL] [Abstract][Full Text] [Related]
5. Proteomic profiling of peritoneal dialysis effluent-derived extracellular vesicles: a longitudinal study.
Carreras-Planella L; Soler-Majoral J; Rubio-Esteve C; Morón-Font M; Franquesa M; Bonal J; Troya-Saborido MI; Borràs FE
J Nephrol; 2019 Dec; 32(6):1021-1031. PubMed ID: 31617158
[TBL] [Abstract][Full Text] [Related]
6. PPAR-γ agonist rosiglitazone ameliorates peritoneal deterioration in peritoneal dialysis rats with LPS-induced peritonitis through up-regulation of AQP-1 and ZO-1.
Zhang Y; Feng J; Wang Q; Zhao S; Xu J; Li H
Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29871973
[TBL] [Abstract][Full Text] [Related]
7. The Role of NGAL in Peritoneal Dialysis Effluent in Early Diagnosis of Peritonitis: Case-Control Study in Peritoneal Dialysis Patients.
Martino F; Scalzotto E; Giavarina D; Rodighiero MP; Crepaldi C; Day S; Ronco C
Perit Dial Int; 2015; 35(5):559-65. PubMed ID: 25395499
[TBL] [Abstract][Full Text] [Related]
8. Proteomics and Extracellular Vesicles as Novel Biomarker Sources in Peritoneal Dialysis in Children.
Trincianti C; Meleca V; La Porta E; Bruschi M; Candiano G; Garbarino A; Kajana X; Preda A; Lugani F; Ghiggeri GM; Angeletti A; Esposito P; Verrina E
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628461
[TBL] [Abstract][Full Text] [Related]
9. Peritoneal Cell-free DNA: an innovative method for determining acute cell damage in peritoneal membrane and for monitoring the recovery process after peritonitis.
Virzì GM; Milan Manani S; Brocca A; Cantaluppi V; de Cal M; Pastori S; Tantillo I; Zambon R; Crepaldi C; Ronco C
J Nephrol; 2016 Feb; 29(1):111-8. PubMed ID: 26012380
[TBL] [Abstract][Full Text] [Related]
10. Orosomucoid can predict baseline peritoneal transport characteristics in peritoneal dialysis patients and reduce peritoneal proteins loss.
Bao M; Sun Z; Yang X; Ji J; Zhang L; Xiang B; Yan G; Ding X; Zou J; Yu X
J Proteomics; 2021 Jun; 242():104260. PubMed ID: 33965627
[TBL] [Abstract][Full Text] [Related]
11. Exploring the Role of Cell-Free Nucleic Acids and Peritoneal Dialysis: A Narrative Review.
Morisi N; Virzì GM; Ferrarini M; Alfano G; Zanella M; Ronco C; Donati G
Genes (Basel); 2024 Apr; 15(5):. PubMed ID: 38790182
[TBL] [Abstract][Full Text] [Related]
12. Peritoneal inflammation and fibrosis in C-reactive protein transgenic mice undergoing peritoneal dialysis solution treatment.
Poon PY; Lan HY; Kwan BC; Huang XR; Chow KM; Szeto CC; Li PK
Nephrology (Carlton); 2017 Feb; 22(2):125-132. PubMed ID: 26857687
[TBL] [Abstract][Full Text] [Related]
13. Restoration of peritoneal integrity after withdrawal of peritoneal dialysis: characteristic features of the patients at risk of encapsulating peritoneal sclerosis.
Otsuka Y; Nakayama M; Ikeda M; Sherif AM; Yokoyama K; Yamamoto H; Kawaguchi Y
Clin Exp Nephrol; 2005 Dec; 9(4):315-319. PubMed ID: 16362159
[TBL] [Abstract][Full Text] [Related]
14. A cost-effective method to get insight into the peritoneal dialysate effluent proteome.
Araújo JE; Jorge S; Teixeira E Costa F; Ramos A; Lodeiro C; Santos HM; Capelo JL
J Proteomics; 2016 Aug; 145():207-213. PubMed ID: 27216641
[TBL] [Abstract][Full Text] [Related]
15. Effluent and serum protein N-glycosylation is associated with inflammation and peritoneal membrane transport characteristics in peritoneal dialysis patients.
Ferrantelli E; Farhat K; Ederveen ALH; Reiding KR; Beelen RHJ; van Ittersum FJ; Wuhrer M; Dotz V
Sci Rep; 2018 Jan; 8(1):979. PubMed ID: 29343697
[TBL] [Abstract][Full Text] [Related]
16. [Encapsulating peritoneal sclerosis--a serious complication of peritoneal dialysis with not characteristic symptoms].
Kowalewska J; Lichodziejewska-Niemierko M; Liberek T; Mechlińska-Baczkowska J; Nałecz A; Jaśkiewicz K; Rutkowski B
Wiad Lek; 2006; 59(5-6):419-21. PubMed ID: 17017495
[TBL] [Abstract][Full Text] [Related]
17. Mast cell quantification in normal peritoneum and during peritoneal dialysis treatment.
Jiménez-Heffernan JA; Bajo MA; Perna C; del Peso G; Larrubia JR; Gamallo C; Sánchez-Tomero JA; López-Cabrera M; Selgas R
Arch Pathol Lab Med; 2006 Aug; 130(8):1188-92. PubMed ID: 16879021
[TBL] [Abstract][Full Text] [Related]
18. [Peritoneal sclerosis in children under treatment with peritoneal dialysis].
Moriya S; Koshino H; Iitaka K; Kasai N
Nihon Jinzo Gakkai Shi; 2001 May; 43(5):378-83. PubMed ID: 11510225
[TBL] [Abstract][Full Text] [Related]
19. Factors increasing severity of peritonitis in long-term peritoneal dialysis patients.
Park MS
Adv Ren Replace Ther; 1998 Jul; 5(3):185-93. PubMed ID: 9686629
[TBL] [Abstract][Full Text] [Related]
20. [Sclerosing peritonitis without reduced ultrafiltration as complication of peritoneal dialysis].
von Schnakenburg C; Pohl M; Häffner K; Zimmerhackl LB; Brandis M
Klin Padiatr; 2005; 217(1):41-4. PubMed ID: 15640972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
